Loading…

β-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study

Purpose Severe traumatic brain injury (TBI) is the predominant cause of death and disability following trauma. Several studies have observed improved survival in TBI patients exposed to β-blockers, however, the effect on functional outcome is poorly documented. Methods Adult patients with severe TBI...

Full description

Saved in:
Bibliographic Details
Published in:European journal of trauma and emergency surgery (Munich : 2007) 2017-12, Vol.43 (6), p.783-789
Main Authors: Ahl, R., Thelin, E. P., Sjölin, G., Bellander, B.-M., Riddez, L., Talving, P., Mohseni, S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c595t-38f4a98f866bdfb56a70bc60bf2d6db5de053f647112c7bdd2637597526e9393
cites cdi_FETCH-LOGICAL-c595t-38f4a98f866bdfb56a70bc60bf2d6db5de053f647112c7bdd2637597526e9393
container_end_page 789
container_issue 6
container_start_page 783
container_title European journal of trauma and emergency surgery (Munich : 2007)
container_volume 43
creator Ahl, R.
Thelin, E. P.
Sjölin, G.
Bellander, B.-M.
Riddez, L.
Talving, P.
Mohseni, S.
description Purpose Severe traumatic brain injury (TBI) is the predominant cause of death and disability following trauma. Several studies have observed improved survival in TBI patients exposed to β-blockers, however, the effect on functional outcome is poorly documented. Methods Adult patients with severe TBI (head AIS ≥ 3) were identified from a prospectively collected TBI database over a 5-year period. Patients with neurosurgical ICU length of stay
doi_str_mv 10.1007/s00068-017-0779-5
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_498544</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1876492744</sourcerecordid><originalsourceid>FETCH-LOGICAL-c595t-38f4a98f866bdfb56a70bc60bf2d6db5de053f647112c7bdd2637597526e9393</originalsourceid><addsrcrecordid>eNp1kstu1DAUhiMEou3AA7BBltiwIOBLbMcsKpVylSqxqdhajuPMeJrEg-20mjVv1AfhmTjDTIcWaRa2j-zvP8fH_oviBcFvCcbyXcIYi7rERJZYSlXyR8UxqQUrlarI433M2FFxktISYCw4fVoc0ZpKXrPquPj1-7b80Ad75SIyXYY5uWsXHcrRTIPJ3qImGj8iPy6nuEY-IZNSsN5k16IbnxeocXmj68M4LyEYUDeNNvswmh6FKdswuPfIIEhmF6CxJjlkw5hj6FHKU7t-VjzpTJ_c8906Ky4_f7o8_1pefP_y7fzsorRc8VyyuquMqrtaiKbtGi6MxI0VuOloK9qGtw5z1olKEkKtbNqWCia5kpwKp5his6Lcpk03bjU1ehX9YOJaB-P1busKIqcrVfOqAl4d5FcxtP9Ed0LCJCWVFBvtm4Paj_7HmQ5xDmPSXLIaA366xYEdXGsdvI7pH1Z8cDL6hZ6Ha5BjSaHPWfF6lyCGn5NLWQ8-Wdf3ZnRhSprUcCtF5d-2Xv2HLsMU4bOAUhJTzCglQJEtZWNIKbpufxmC9cZ8ems-DebTG_NpDpqX97vYK-7cBgDdvQocjXMX75U-mPUP2jDqTg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1970203221</pqid></control><display><type>article</type><title>β-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study</title><source>Springer Nature</source><creator>Ahl, R. ; Thelin, E. P. ; Sjölin, G. ; Bellander, B.-M. ; Riddez, L. ; Talving, P. ; Mohseni, S.</creator><creatorcontrib>Ahl, R. ; Thelin, E. P. ; Sjölin, G. ; Bellander, B.-M. ; Riddez, L. ; Talving, P. ; Mohseni, S.</creatorcontrib><description>Purpose Severe traumatic brain injury (TBI) is the predominant cause of death and disability following trauma. Several studies have observed improved survival in TBI patients exposed to β-blockers, however, the effect on functional outcome is poorly documented. Methods Adult patients with severe TBI (head AIS ≥ 3) were identified from a prospectively collected TBI database over a 5-year period. Patients with neurosurgical ICU length of stay &lt;48 h and those dying within 48 h of admission were excluded. Patients exposed to β-blockers ≤ 48 h after admission and who continued with treatment until discharge constituted β-blocked cases and were matched to non β-blocked controls using propensity score matching. The outcome of interest was Glasgow Outcome Scores (GOS), as a measure of functional outcome up to 12 months after injury. GOS ≤ 3 was considered a poor outcome. Bivariate analysis was deployed to determine differences between groups. Odds ratio and 95% CI were used to assess the effect of β-blockers on GOS. Results 362 patients met the inclusion criteria with 21% receiving β-blockers during admission. After propensity matching, 76 matched pairs were available for analysis. There were no statistical differences in any variables included in the analysis. Mean hospital length of stay was shorter in the β-blocked cases (18.0 vs. 26.8 days, p  &lt; 0.01). The risk of poor long-term functional outcome was more than doubled in non-β-blocked controls (OR 2.44, 95% CI 1.01–6.03, p  = 0.03). Conclusion Exposure to β-blockers in patients with severe TBI appears to improve functional outcome. Further prospective randomized trials are warranted.</description><identifier>ISSN: 1863-9933</identifier><identifier>ISSN: 1863-9941</identifier><identifier>EISSN: 1863-9941</identifier><identifier>DOI: 10.1007/s00068-017-0779-5</identifier><identifier>PMID: 28275834</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adrenergic beta-Antagonists - administration &amp; dosage ; Adrenergic beta-Antagonists - therapeutic use ; Brain Injuries, Traumatic - drug therapy ; Brain Injuries, Traumatic - mortality ; Brain Injuries, Traumatic - rehabilitation ; Case-Control Studies ; Critical Care Medicine ; Emergency Medicine ; Female ; Glasgow Coma Scale ; Humans ; Injury Severity Score ; Intensive ; Kirurgi ; Length of Stay ; Male ; Medicin och hälsovetenskap ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Original ; Original Article ; Recovery of Function ; Sports Medicine ; Surgery ; Surgical Orthopedics ; Survival Analysis ; Sweden ; Traumatic brain injury ; Traumatic Surgery</subject><ispartof>European journal of trauma and emergency surgery (Munich : 2007), 2017-12, Vol.43 (6), p.783-789</ispartof><rights>The Author(s) 2017</rights><rights>European Journal of Trauma and Emergency Surgery is a copyright of Springer, (2017). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c595t-38f4a98f866bdfb56a70bc60bf2d6db5de053f647112c7bdd2637597526e9393</citedby><cites>FETCH-LOGICAL-c595t-38f4a98f866bdfb56a70bc60bf2d6db5de053f647112c7bdd2637597526e9393</cites><orcidid>0000-0001-7097-487X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28275834$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-57380$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:137214764$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahl, R.</creatorcontrib><creatorcontrib>Thelin, E. P.</creatorcontrib><creatorcontrib>Sjölin, G.</creatorcontrib><creatorcontrib>Bellander, B.-M.</creatorcontrib><creatorcontrib>Riddez, L.</creatorcontrib><creatorcontrib>Talving, P.</creatorcontrib><creatorcontrib>Mohseni, S.</creatorcontrib><title>β-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study</title><title>European journal of trauma and emergency surgery (Munich : 2007)</title><addtitle>Eur J Trauma Emerg Surg</addtitle><addtitle>Eur J Trauma Emerg Surg</addtitle><description>Purpose Severe traumatic brain injury (TBI) is the predominant cause of death and disability following trauma. Several studies have observed improved survival in TBI patients exposed to β-blockers, however, the effect on functional outcome is poorly documented. Methods Adult patients with severe TBI (head AIS ≥ 3) were identified from a prospectively collected TBI database over a 5-year period. Patients with neurosurgical ICU length of stay &lt;48 h and those dying within 48 h of admission were excluded. Patients exposed to β-blockers ≤ 48 h after admission and who continued with treatment until discharge constituted β-blocked cases and were matched to non β-blocked controls using propensity score matching. The outcome of interest was Glasgow Outcome Scores (GOS), as a measure of functional outcome up to 12 months after injury. GOS ≤ 3 was considered a poor outcome. Bivariate analysis was deployed to determine differences between groups. Odds ratio and 95% CI were used to assess the effect of β-blockers on GOS. Results 362 patients met the inclusion criteria with 21% receiving β-blockers during admission. After propensity matching, 76 matched pairs were available for analysis. There were no statistical differences in any variables included in the analysis. Mean hospital length of stay was shorter in the β-blocked cases (18.0 vs. 26.8 days, p  &lt; 0.01). The risk of poor long-term functional outcome was more than doubled in non-β-blocked controls (OR 2.44, 95% CI 1.01–6.03, p  = 0.03). Conclusion Exposure to β-blockers in patients with severe TBI appears to improve functional outcome. Further prospective randomized trials are warranted.</description><subject>Adrenergic beta-Antagonists - administration &amp; dosage</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Brain Injuries, Traumatic - drug therapy</subject><subject>Brain Injuries, Traumatic - mortality</subject><subject>Brain Injuries, Traumatic - rehabilitation</subject><subject>Case-Control Studies</subject><subject>Critical Care Medicine</subject><subject>Emergency Medicine</subject><subject>Female</subject><subject>Glasgow Coma Scale</subject><subject>Humans</subject><subject>Injury Severity Score</subject><subject>Intensive</subject><subject>Kirurgi</subject><subject>Length of Stay</subject><subject>Male</subject><subject>Medicin och hälsovetenskap</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Original Article</subject><subject>Recovery of Function</subject><subject>Sports Medicine</subject><subject>Surgery</subject><subject>Surgical Orthopedics</subject><subject>Survival Analysis</subject><subject>Sweden</subject><subject>Traumatic brain injury</subject><subject>Traumatic Surgery</subject><issn>1863-9933</issn><issn>1863-9941</issn><issn>1863-9941</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kstu1DAUhiMEou3AA7BBltiwIOBLbMcsKpVylSqxqdhajuPMeJrEg-20mjVv1AfhmTjDTIcWaRa2j-zvP8fH_oviBcFvCcbyXcIYi7rERJZYSlXyR8UxqQUrlarI433M2FFxktISYCw4fVoc0ZpKXrPquPj1-7b80Ad75SIyXYY5uWsXHcrRTIPJ3qImGj8iPy6nuEY-IZNSsN5k16IbnxeocXmj68M4LyEYUDeNNvswmh6FKdswuPfIIEhmF6CxJjlkw5hj6FHKU7t-VjzpTJ_c8906Ky4_f7o8_1pefP_y7fzsorRc8VyyuquMqrtaiKbtGi6MxI0VuOloK9qGtw5z1olKEkKtbNqWCia5kpwKp5his6Lcpk03bjU1ehX9YOJaB-P1busKIqcrVfOqAl4d5FcxtP9Ed0LCJCWVFBvtm4Paj_7HmQ5xDmPSXLIaA366xYEdXGsdvI7pH1Z8cDL6hZ6Ha5BjSaHPWfF6lyCGn5NLWQ8-Wdf3ZnRhSprUcCtF5d-2Xv2HLsMU4bOAUhJTzCglQJEtZWNIKbpufxmC9cZ8ems-DebTG_NpDpqX97vYK-7cBgDdvQocjXMX75U-mPUP2jDqTg</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Ahl, R.</creator><creator>Thelin, E. P.</creator><creator>Sjölin, G.</creator><creator>Bellander, B.-M.</creator><creator>Riddez, L.</creator><creator>Talving, P.</creator><creator>Mohseni, S.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>AABEP</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>D91</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0001-7097-487X</orcidid></search><sort><creationdate>20171201</creationdate><title>β-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study</title><author>Ahl, R. ; Thelin, E. P. ; Sjölin, G. ; Bellander, B.-M. ; Riddez, L. ; Talving, P. ; Mohseni, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c595t-38f4a98f866bdfb56a70bc60bf2d6db5de053f647112c7bdd2637597526e9393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adrenergic beta-Antagonists - administration &amp; dosage</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Brain Injuries, Traumatic - drug therapy</topic><topic>Brain Injuries, Traumatic - mortality</topic><topic>Brain Injuries, Traumatic - rehabilitation</topic><topic>Case-Control Studies</topic><topic>Critical Care Medicine</topic><topic>Emergency Medicine</topic><topic>Female</topic><topic>Glasgow Coma Scale</topic><topic>Humans</topic><topic>Injury Severity Score</topic><topic>Intensive</topic><topic>Kirurgi</topic><topic>Length of Stay</topic><topic>Male</topic><topic>Medicin och hälsovetenskap</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Original Article</topic><topic>Recovery of Function</topic><topic>Sports Medicine</topic><topic>Surgery</topic><topic>Surgical Orthopedics</topic><topic>Survival Analysis</topic><topic>Sweden</topic><topic>Traumatic brain injury</topic><topic>Traumatic Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahl, R.</creatorcontrib><creatorcontrib>Thelin, E. P.</creatorcontrib><creatorcontrib>Sjölin, G.</creatorcontrib><creatorcontrib>Bellander, B.-M.</creatorcontrib><creatorcontrib>Riddez, L.</creatorcontrib><creatorcontrib>Talving, P.</creatorcontrib><creatorcontrib>Mohseni, S.</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SWEPUB Örebro universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Örebro universitet</collection><collection>SwePub Articles full text</collection><jtitle>European journal of trauma and emergency surgery (Munich : 2007)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahl, R.</au><au>Thelin, E. P.</au><au>Sjölin, G.</au><au>Bellander, B.-M.</au><au>Riddez, L.</au><au>Talving, P.</au><au>Mohseni, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>β-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study</atitle><jtitle>European journal of trauma and emergency surgery (Munich : 2007)</jtitle><stitle>Eur J Trauma Emerg Surg</stitle><addtitle>Eur J Trauma Emerg Surg</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>43</volume><issue>6</issue><spage>783</spage><epage>789</epage><pages>783-789</pages><issn>1863-9933</issn><issn>1863-9941</issn><eissn>1863-9941</eissn><abstract>Purpose Severe traumatic brain injury (TBI) is the predominant cause of death and disability following trauma. Several studies have observed improved survival in TBI patients exposed to β-blockers, however, the effect on functional outcome is poorly documented. Methods Adult patients with severe TBI (head AIS ≥ 3) were identified from a prospectively collected TBI database over a 5-year period. Patients with neurosurgical ICU length of stay &lt;48 h and those dying within 48 h of admission were excluded. Patients exposed to β-blockers ≤ 48 h after admission and who continued with treatment until discharge constituted β-blocked cases and were matched to non β-blocked controls using propensity score matching. The outcome of interest was Glasgow Outcome Scores (GOS), as a measure of functional outcome up to 12 months after injury. GOS ≤ 3 was considered a poor outcome. Bivariate analysis was deployed to determine differences between groups. Odds ratio and 95% CI were used to assess the effect of β-blockers on GOS. Results 362 patients met the inclusion criteria with 21% receiving β-blockers during admission. After propensity matching, 76 matched pairs were available for analysis. There were no statistical differences in any variables included in the analysis. Mean hospital length of stay was shorter in the β-blocked cases (18.0 vs. 26.8 days, p  &lt; 0.01). The risk of poor long-term functional outcome was more than doubled in non-β-blocked controls (OR 2.44, 95% CI 1.01–6.03, p  = 0.03). Conclusion Exposure to β-blockers in patients with severe TBI appears to improve functional outcome. Further prospective randomized trials are warranted.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>28275834</pmid><doi>10.1007/s00068-017-0779-5</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-7097-487X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1863-9933
ispartof European journal of trauma and emergency surgery (Munich : 2007), 2017-12, Vol.43 (6), p.783-789
issn 1863-9933
1863-9941
1863-9941
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_498544
source Springer Nature
subjects Adrenergic beta-Antagonists - administration & dosage
Adrenergic beta-Antagonists - therapeutic use
Brain Injuries, Traumatic - drug therapy
Brain Injuries, Traumatic - mortality
Brain Injuries, Traumatic - rehabilitation
Case-Control Studies
Critical Care Medicine
Emergency Medicine
Female
Glasgow Coma Scale
Humans
Injury Severity Score
Intensive
Kirurgi
Length of Stay
Male
Medicin och hälsovetenskap
Medicine
Medicine & Public Health
Middle Aged
Original
Original Article
Recovery of Function
Sports Medicine
Surgery
Surgical Orthopedics
Survival Analysis
Sweden
Traumatic brain injury
Traumatic Surgery
title β-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A52%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%B2-Blocker%20after%20severe%20traumatic%20brain%20injury%20is%20associated%20with%20better%20long-term%20functional%20outcome:%20a%20matched%20case%20control%20study&rft.jtitle=European%20journal%20of%20trauma%20and%20emergency%20surgery%20(Munich%20:%202007)&rft.au=Ahl,%20R.&rft.date=2017-12-01&rft.volume=43&rft.issue=6&rft.spage=783&rft.epage=789&rft.pages=783-789&rft.issn=1863-9933&rft.eissn=1863-9941&rft_id=info:doi/10.1007/s00068-017-0779-5&rft_dat=%3Cproquest_swepu%3E1876492744%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c595t-38f4a98f866bdfb56a70bc60bf2d6db5de053f647112c7bdd2637597526e9393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1970203221&rft_id=info:pmid/28275834&rfr_iscdi=true